Since colchicine-sensitive microtubules regulate the expression and topography of surface glycoproteins on a variety of cells, we sought evidence that colchicine interferes with neutrophil-endothelial interactions by altering the number and/or distribution of selectins on endothelial cells and neutrophils. Extremely low, prophylactic, concentrations of colchicine (IC50 = 3 nM) eliminated the E-selectin-mediated increment in endothelial adhesiveness for neutrophils in response to IL-1 (P < 0.001) or TNF alpha (P < 0.001) by changing the distribution, but not the number, of E-selectin molecules on the surface of the endothelial cells. Colchicine inhibited stimulated endothelial adhesiveness via its effects on microtubules since vinblastine, an agent which perturbs microtubule function by other mechanisms, diminished adhesiveness whereas the photoinactivated colchicine derivative gamma-lumicolchicine was inactive. Colchicine had no effect on cell viability. At higher, therapeutic, concentrations colchicine (IC50 = 300 nM, P < 0.001) also diminished the expression of L-selectin on the surface of neutrophils (but not lymphocytes) without affecting expression of the beta 2-integrin CD11b/CD18. In confirmation, L-selectin expression was strikingly reduced (relative to CD11b/CD18 expression) on neutrophils from two individuals who had ingested therapeutic doses of colchicine. These results suggest that colchicine may exert its prophylactic effects on cytokine-provoked inflammation by diminishing the qualitative expression of E-selectin on endothelium, and its therapeutic effects by diminishing the quantitative expression of L-selectin on neutrophils.
Introduction
Although colchicine has been used to treat inflammatory diseases for nearly 3,000 years, the basis of its antiphlogistic action remains unclear. Colchicine's major effect on cells is inhibition of microtubule assembly, cytoskeletal polymers of tubulin dimers which undergo assembly and disassembly at opposing termini of the tubule. Colchicine, by site-specific binding to tubulin, prevents tubulin assembly into multimers without inhibiting microtubule disassembly; the net result is microtubule disruption (1) . In neutrophils, for example, where colchicine (5 MM) prevents degranulation in response to ligation of Fc receptors, it reduces the number of centriolar microtubules/Mm2 from 14 to 6 (2) . However, it is uncertain whether disassembly of neutrophil microtubules is responsible for the in vivo antiinflammatory effects of colchicine since concentrations greater than those achieved during therapy (1 MM vs 100 nM) are required to inhibit microtubule-dependent functions (3) (4) (5) (6) .
Microtubules, in concert with other proteins of the cytoskeleton, not only regulate the display of surface molecules but also their function (2, (6) (7) (8) (9) . Indeed, colchicine, by a microtubuledependent mechanism, enhances capping of concanavalin Abinding glycoproteins ( 10) but diminishes surface expression of receptors for TNFa (6) , insulin (9) , and /3-adrenergic agonists ( 11) . Colchicine also inhibits assembly of the leukotreineB4-forming complex at the plasma membrane (5) , affects the interactions of heterotrimeric G proteins with the catalytic subunit of adenylate cyclase (13) , increases intracellular cAMP (14) , and enhances the synthesis of stable prostaglandins (15) . Each of these effects, shared with vinblastine and nocodazole but not lumicolchicine, has been held responsible for one or another of the effects of colchicine in inflammation.
Many of the adhesive molecules which mediate the interaction of leukocytes with the endothelium (selectins, integrins, cell adhesion molecules) have recently been identified and their role in inflammation precisely elucidated (reviewed in reference 16) . We now report evidence that colchicine alters the function and expression of adhesive molecules on endothelium and leukocytes by virtue of its effects on microtubules.
Methods
Monoclonal antibodies. Murine 
Results
Effect of colchicine on endothelial adhesiveness. Activation of endothelial cells by either IL-I ( 10 U/ml) or TNFa ( 100 U/ml) leads to increased adhesiveness for resting neutrophils which is detectable 1-2 h after stimulation and which is maximal by 4 h after addition of the stimulus (23). The increased adhesiveness of activated endothelial cells for resting neutrophils is due, in large measure, to the de novo expression of the adhesive molecule E-selectin on the surface of endothelial cells (24) (25) (26) (27) . After 4 h of incubation, IL-I and TNFa induced a maximal two to threefold increase in adhesion of leukocytes to endothelial cells (from 31±5 to 71±5 or 108±11 adherent PMNs/X200 field, respectively, both P < 0.001, Fig. 1 consistent with the well-described effects of colchicine on cell spreading (28) . Nearly identical results were obtained when stimulated endothelial cells were treated with nocodazole (50 y). Thus, disruption of microtubules in endothelial ttM), an agent that also disrupts microtubules by a mechanism extremely low concentrations of colchicine (with an that differs from that of colchicine (Fig. 5) . In contrast, colchi-10 nM) and vinblastine (10 ,uM) almost completely cine did not affect the display of ICAM-1 on the surface of d the stimulated increment in adhesion of neutrophils stimulated (or resting, data not shown) endothelial cells (Fig.  ielial cells. 5). The effects of colchicine on cell shape and E-selectin display t ofcolchicine on the quantitative display of E-selectin.
were not due to cytotoxicity since colchicine did not affect e the mechanism by which colchicine and vinblastine 51Cr release from labeled endothelial cells (27±10 vs 30±7% endothelial adhesiveness for leukocytes we determined release, control vs colchicine 10 jiM, n = 3). It is therefore t of colchicine and vinblastine on the cytokine-stimulikely that colchicine, at all concentrations, diminished endothe-)ression of E-selectin using a cell-based ELISA. Sur-lial adhesiveness for neutrophils by changing the quality, but in view of their profound inhibition of adhesiveness, not the quantity, of E-selectin displayed on the surface of endo-,olchicine (up to 10 jLM) nor vinblastine (10 4M) thelial cells.
red the global expression of E-selectin by endothelial Effect of colchicine on leukocyte adhesion molecules in vated with either IL-1 or TNFa (Fig. 4) . We therefore vitro. Leukocytes also express adhesive molecules, e.g., L-sethat colchicine might alter the topologic display of Electin (related to E-selectin) and CDl lb/CD 18, the display of on cytokine-stimulated endothelial cells, i.e., that the which might be affected by colchicine. Since our previous stud- ies (2, 5) documented a 75% reduction in the number of centriolar microtubules after treatment of neutrophils with colchicine (5 tzM, 30 min) we determined the effects of colchicine on the expression of adhesive molecules on these cells. Colchicine markedly diminished expression of L-selectin on the surface of neutrophils with an ICM of 300 nM (Figs. 6 and 7) . Vinblastine (10 MM) diminished L-selectin expression as readily as colchicine (40±10% reduction, P < 0.03 vs control, n = 3, Fig. 6 ) but y-lumicolchicine had no effect on expression of L-selectin (5±5% reduction, P = NS vs control, n = 8). These effects were specific with respect to L-selectin and did not simply change constitutive display of an adhesion molecule since nei- ther colchicine nor vinblastine affected expression of the 12-integrin CD1 lb/CD18 (Fig. 6) . Moreover, neither colchicine nor vinblastine affected nonspecific fluorescence after exposure of cells to isotype control antibody MOPC 21 (104±6% of control, n = 4). Finally, in contrast to its effect on neutrophils, colchicine had no effect on the expression of L-selectin by lymphocytes (Fig. 6) . Effect ofcolchicine on leukocyte adhesion molecules in vivo. Finally we determined whether the in vitro effects of colchicine on neutrophil L-selectin expression were relevant to the antiinflammatory effects of colchicine in vivo. We examined neutrophil expression of L-selectin and CD1lb/CD18 expression before, during, and after volunteers had ingested colchicine in a [Colchicinel (pM) treatment protocol we routinely use to treat acute gouty arthritis (0.5 mg every hour for five hours). As shown in Fig. 8 , Lselectin expression relative to CD1 lb/CD18 expression on neutrophils from each of the two volunteers significantly decreased with colchicine. In one of the individuals so treated L-selectin expression returned to baseline 18 h after the last dose of colchicine whereas in the other individual L-selectin expression returned only partially to baseline by the next day.
Discussion
Since the work of Cohnheim (29) it has been appreciated that the first step in the pathogenesis of inflammation is the adhesion of leukocytes to endothelial cells. We report here that colchicine, the oldest antiinflammatory drug, dramatically reduces the adhesion of leukocytes to endothelium.
The studies reported here demonstrate that endothelial adhesiveness for neutrophils appears to depend on intact microtubules since agents which disrupt microtubules (colchicine and vinblastine), but not their inactive analogues (y-lumicolchicine), almost completely inhibited stimulated endothelial adhesiveness for neutrophils. Moreover, our data strongly suggest that colchicine and other microtubule-disrupting agents abrogate endothelial adhesiveness by modulating the topography but not the number of E-selectin molecules on the surface of the stimulated endothelial cell (a qualitative rather than a quantitative effect). These observations are consistent with other effects of microtubule disruption on capping and redistribution of surface ligands and receptors (2, (6) (7) (8) (9) . Although the apparent effect of colchicine was by no means as marked on other endothelial adhesive proteins these data do not exclude the possibility that colchicine affects their expression and adhesiveness.
Kuijpers et al. have recently reported that internalization of E-selectin from the surface of endothelial cells and its localization to a lysosomal compartment requires intact microtubules since internalization is blocked by colchicine and vinblastine (30). Our observations are in accord with Kuijpers' report and indicate that there is a critical association between E-selectin and the tubulin-containing cytoskeleton required for both the appropriate trafficking of E-selectin (30) and the ability of Eselectin to mediate adhesion for neutrophils.
Colchicine (IC50 = 3 nM) diminished endothelial adhesiveness for neutrophils whether present during stimulation of endothelial cells with cytokines (TNFa, IL-i) or after maximal stimulation of endothelial E-selectin expression. Similarly, colchicine modulated the distribution, but not the number, of E-selectin molecules on stimulated endothelial cells whether colchicine was added during or after stimulation of endothelial E-selectin expression. The parallel effects of colchicine on endothelial adhesiveness and the topography of E-selectin suggest that the redistribution and/or altered expression of E-selectin on the surface of the endothelial cell led to changes in endothelial adhesiveness. An alternative explanation for the capacity of colchicine to diminish endothelial adhesiveness is suggested by the observation that the cytoplasmic portion of L-selectin, a molecule closely related to E-selectin, regulates its adhesiveness and that disruption of actin filaments, a component of the cytoskeleton, diminishes L-selectin-mediated adhesion (31) . The data do not, however, permit conclusions as to whether E-selectin is the only target for colchicine's effects.
Ding and co-workers (6) have previously reported that colchicine diminishes, by 70-75%, the number of TNF receptors on endothelial cells. We were therefore surprised that colchicine failed to decrease the expression of E-selectin stimulated by TNF. Since we used saturating concentrations of TNF (100 U/ ml) to stimulate endothelial cells, our results indicate that those receptors remaining on the cell surface after colchicine treatment are active. Moreover, the observation that TNF stimulates a maximal response despite colchicine-induced loss of up to 75% of the cellular receptors for TNF suggests that TNF must occupy only a small fraction of its receptors to elicit a maximal response.
Previous studies by Asako et al. (32) showed that high concentrations of colchicine increase the rolling velocity of leukocytes in the microcirculation. The increased rolling velocity of leukocytes observed in the presence of colchicine is consistent with diminished adhesive interactions (L-selectin-dependent) between circulating leukocytes and the microvascular endothelium. Indeed, our observation provides a mechanism for the impaired adhesion between leukocytes and endothelial cells observed by Asako et al. (32) . Since it is likely that diminished expression of L-selectin on neutrophils induced by high concentrations of colchicine accounts for the drug's inhibition of leukocyte migration from blood vessels (32), our studies and those of Asako et al. support the contention that L-selectin-mediated rolling of leukocytes is required for the accumulation of leukocytes at inflamed sites (33) . (8) . Our data do not permit us to discriminate between these possibilities. Recent reports suggest that the impact of colchicine on signalling events in the neutrophil may underlie the therapeutic efficacy of this agent in the treatment of acute gouty arthritis. Gaudry and colleagues have recently reported that monosodium urate crystals induce a specific pattern of tyrosine phosphorylation in neutrophils (38) . In a subsequent study this same group reported that colchicine blocks crystal-stimulated, but not chemoattractant-stimulated, protein tyrosine phosphorylation in neutrophils (39) . As the effect of colchicine on protein tyrosine phosphorylation in monosodium urate crystal-stimulated neutrophils can be achieved at concentrations which may be achieved pharmacologically during treatment of acute gouty L attacks (.: 100 nM), it is likely that inhibition by colchicine *1000 Cronstein et al. a of neutrophil responses to monosodium urate crystals also contribute to the therapeutic efficacy of colchicine in the therapy of acute gouty arthritis. The concentrations of colchicine that inhibit adhesion of neutrophils to stimulated endothelial cells are 100-1,000-fold lower than those which have been reported previously to alter other functions of inflammatory cells (e.g., degranulation, leukotriene B4 synthesis, increased cAMP [2, 40] ). The extremely low concentrations of colchicine which inhibit stimulated adhesion of neutrophils to endothelial cells are consistent with those that can be achieved ( < 10 nM) in the treatment of acute attacks of gout or Familial Mediterranean Fever (0.6 mg/d). Indeed, the observations reported here suggest the first explanation for the efficacy of colchicine in preventing, in contrast to treating, acute gouty arthritis. In acute gout, endothelial cells of the synovium respond to urate crystal-induced release of TNF by expressing adhesive molecules which attract neutrophils into the joint space (41) . But when low, prophylactic doses of colchicine, which yield nanomolar concentrations, alter the display of E-selectin on stimulated endothelial cells, neutrophils can ignore the quiescent endothelium. Higher concentrations of colchicine, such as those achieved in the treatment of established gouty arthritis (up to 4 mg/d, sufficient to achieve micromolar concentrations in cells), affect not only the endothelium but also promote loss of L-selectin from neutrophils which, in consequence, are unable to stick to endothelium.
